wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24633710-2A48E0CB-E18E-450E-966F-C624D1F20B7E
Q24633710-2A48E0CB-E18E-450E-966F-C624D1F20B7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-2A48E0CB-E18E-450E-966F-C624D1F20B7E
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
P2860
Q24633710-2A48E0CB-E18E-450E-966F-C624D1F20B7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-2A48E0CB-E18E-450E-966F-C624D1F20B7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
114b32941c4e838a06e57ff04c844d39d96c4860
P2860
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).